SCHEMBL2915028

SCHEMBL2915028

O=C(NC1CCCCC1)C(C1CCCCC1)C1(C(O)c2ccccn2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
MET P08581 1/20 0.39
KDR P35968 1/20 0.39
MERTK Q12866 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KDM4E B2RXH2 2/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
C3AR1 Q16581 1/20 0.36
EPHX2 P34913 1/20 0.36
FFAR2 O15552 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913040 0.85 TSHR (0.44) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL4040310 0.82 EGFR (0.41) KMT2AMEN1ALDH1A1SMN1; SMN2EGFR
SCHEMBL2909615 0.82 C3AR1 (0.43) ALDH1A1SMN1; SMN2KDM4EC3AR1
SCHEMBL2915021 0.79 KCNH2 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9AHPGD
SCHEMBL2907592 0.79 NPC1 (0.42) KMT2AMEN1SMN1; SMN2NPC1RAB9A
SCHEMBL2912425 0.79 TSHR (0.40) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL2906901 0.78 CNR1 (0.40) KMT2AMEN1ALDH1A1SMN1; SMN2NPC1
SCHEMBL4041039 0.76 CYP3A4 (0.41) KMT2AMEN1SMN1; SMN2EGFRERBB2
SCHEMBL2910028 0.76 SMN1; SMN2 (0.45) KMT2AMEN1ALDH1A1GAASMN1; SMN2
SCHEMBL2912649 0.74 KMT2A (0.39) KMT2AMEN1ALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed